Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scil Technology GmbH

Latest From Scil Technology GmbH

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device

Scil Technology assets bought out by Nanohale

Nanohale, a German firm developing new formulations of protein and peptide therapeutics, has acquired the R&D and contract development and manufacturing services assets of Scil Technology, bringing them into a new wholly owned subsidiary called Formycon.


Sanofi licenses regenerative osteoarthritis treatment from Scil

Sanofi has exclusively licensed Scil Technology's preclinical stage programme for a regenerative treatment of osteoarthritis and cartilage disorders.

Orthopedics Germany

Scil Technology appoints Christian Nafe to CEO

Scil Technology, the German protein drug development and formulation company, has appointed Christian Nafe, currently CFO of the company, to CEO. Mr Nafe succeeds Dr. Weishui Weiser, who retires after 5 years as managing director of Scil Technology.

See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes